Polycystic ovary syndrome and risk of uterine leiomyomata

Fertil Steril. 2007 May;87(5):1108-15. doi: 10.1016/j.fertnstert.2006.11.012. Epub 2007 Jan 22.

Abstract

Objective: To examine the association between polycystic ovary syndrome (PCOS) and the risk of uterine leiomyomata (UL).

Design: Prospective cohort study.

Setting: Participants from the Black Women's Health Study, an ongoing prospective cohort study of African-American women aged 21-69 years in 1995 residing in the United States. Participants completed mailed questionnaires about their health status every 2 years.

Patient(s): Premenopausal women with no history of UL at the start of follow-up (N = 23,571).

Intervention(s): No interventions were administered.

Main outcome measure: Incidence of UL among those with and without self-reported, physician-diagnosed PCOS over a 6-year period of follow-up (1997-2003). Medical-record validation in a random subset of UL cases confirmed 96% of diagnoses.

Result(s): During 114,373 person-years of follow-up, 3,631 new cases of UL confirmed by ultrasound (N = 2,926) or hysterectomy (N = 705) were reported. After adjustment for potential confounders, the incidence of UL was 65% higher among women with PCOS than women without PCOS (incidence rate ratio, 1.65; 95% confidence interval, 1.21-2.24). The incidence rate ratios remained constant with increasing time after the diagnosis of PCOS. Results were similar when analyses were confined to women reporting a recent Papanicolaou smear, a proxy for a pelvic examination.

Conclusion(s): The present study suggests a positive association between PCOS and UL in African-American women.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Aged
  • Cohort Studies
  • Female
  • Humans
  • Leiomyoma / complications
  • Leiomyoma / epidemiology*
  • Middle Aged
  • Polycystic Ovary Syndrome / complications
  • Polycystic Ovary Syndrome / epidemiology*
  • Prospective Studies
  • Risk Factors
  • Uterine Neoplasms / complications
  • Uterine Neoplasms / epidemiology*